Neuropathy Hereditary Sensory And Autonomic Type 2a C2752089
A rare inherited neuropathy beginning in childhood that affects sensation. Children may not feel pain or temperature changes, leading to unnoticed injuries.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Sudden fainting spells (syncope)
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Sensory loss in distal extremities
(neurologic)Reduced deep tendon reflexes
(neurologic)Recurrent skin infections
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Neuropathic pain management
Pharmacological approach using first-line agents such as gabapentinoids or tricyclic antidepressants to manage chronic neuropathic pain associated with sensory loss. Treatment is tailored to individual response and side effect profile.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Regular foot and skin examinations
Comprehensive dermatological monitoring to detect early signs of ulceration, infection, or tissue damage in areas with reduced sensation. Includes inspection of pressure points and between toes.
Additional treatment options
Protective footwear and injury prevention
Use of custom-fitted orthopedic shoes and protective padding to prevent unnoticed trauma to insensate feet. Education on avoiding extreme temperatures and sharp objects.
lifestyleGait training and balance exercises
Therapeutic exercises focusing on proprioception compensation, strengthening of supporting muscles, and balance training to reduce fall risk and maintain mobility.
physical_therapyOrthopedic intervention for deformities
Surgical correction of foot deformities such as Charcot arthropathy, hammertoes, or osteomyelitis when conservative management fails to prevent recurrent ulceration.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Neuropathy Hereditary Sensory And Autonomic Type 2a C2752089?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Neuropathy Hereditary Sensory And Autonomic Type 2a C2752089. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy